35 Burst results for "biontech"

The Pfizer-BioNTech Vaccine Is Said to Be Powerfully Protective in Adolescents

Ray Appleton

00:33 sec | Last week

The Pfizer-BioNTech Vaccine Is Said to Be Powerfully Protective in Adolescents

"In Children ages. 12 to 15. The news comes as covert 19 cases are on the rise again. Health officials with the White House covert task force say they're worried about another surge in the U. S. Dr. Anthony Fauci, We have seen now immune protection. Against Cove in 19 variants when individuals of vaccinated against the wild type strain on two mechanisms, the anybody response that has a spillover effect. As well as the cross reactivity. Today, Fresno Kings and Madeira counties

S. Dr. Anthony Fauci Against Cove White House U. Fresno Kings Madeira
Pfizer and BioNTech  trial shows Vaccine is safe

NPR News Now

00:17 sec | Last week

Pfizer and BioNTech trial shows Vaccine is safe

"Biontech say a small clinical trial. They're tracking shows that they're covid. Nineteen vaccine is safe and strongly effective in children. As young as twelve. most co- vaccines are for adults. Although pfizer's shot can be used in people aged sixteen and seventeen stocks

Pfizer
"biontech" Discussed on Mornings With Gail - 1310 KFKA

Mornings With Gail - 1310 KFKA

08:06 min | 2 weeks ago

"biontech" Discussed on Mornings With Gail - 1310 KFKA

"Of impending to if folks keep easing off. We know what to do and we can be responsible humans and it seems to me that this is lapsing into a bit of hyperbole. We'll just put it that way your thoughts this morning nine seven three five. Three thirteen dropped me a text on thirteen ten k. f. k. A text line number for you our new cohort of texters. All you have to do is text. Kfi k. eight to nine seven four seven eight thirteen one the first time you use that number and then you can text away to your heart's content. But do you think it's a little much as we're getting Just all these. Just harrowing warnings from the cdc as you have the head of the cdc's oh impending doom. If people people keep easing off and again a standard disclaimer applies here. I'm not underestimating. I am not minimizing the effects of covid nineteen in the fact that we have seen over half a million people succumb to The worst effects of covid nineteen that we've seen over half a million people in this country alone died due to complications of covid nineteen. But let's just say. I'm a little bit jaded and a little bit skeptical all particularly when it comes to that ever rotating litany of lockdowns and guidelines and restrictions and fearmongering. I think that's the best way to describe it. Fearmongering that is coming out of the centers for disease control. Is it really that necessary. Or is it accomplishing an end game One who's end still remains to be written just asking the question this morning. Nine seven three five three thirteen ten. Meanwhile yet governor. Jared polis announcing Just this past pride or excuse me announcing just yesterday. I believe that the state is expanding vaccinations to pays two. There's the friday reference on friday april. Second now what does that mean for you. Well phase two includes the general public that means colorado and sixteen and older will be eligible for the vaccine. The pfizer vaccine and those eighteen and older will be eligible for both the madonna and the johnson and johnson. Vaccines but yes. This news was delivered in a very cautionary manner. Just because said governor jared polis just because we're opening it up to all colorado ones doesn't mean they'll get it the first weekend. I think we know the drill there. He said it's currently projected that all colorado who want a covid nineteen vaccine will receive it by mid to late may in about six to eight weeks. Paulus repeated his previously stated believe that life in colorado would return to some level of normalcy Maybe that's when the new normal begins by mid june. When asked about the statewide mask mandate police said colorado is moving toward more localized enforcement of covid restrictions. And isn't that how it should be and that the state is targeting april sixteenth to start handing over those decisions to local commissioners and mayors interesting to see. I don't know why. Do i see this tug of war. It's kind of like my puppy rudy. When he's got his rope toy. And it's like mean that needs crawling. Were pulling tugging. I just wonder how that transition to the weld. County commissioners is going to be just asking the question you know that relationship between the weld. County commissioners and governors jared. Police the governor's office. Let's just say it's an interesting a sixth community. Vaccination site is being opened at ball arena in downtown denver. There also be a mobile buses whether mobile distributing vaccines beginning. Next week now the ball arena site will open on april first this according to the colorado department of public health and environment by out to you can start making appointments if you're so inclined at that site now now colorado department of public health and environment said they will distribute two thousand three hundred forty doses of the covid nineteen vaccine on april first and second just right around the corner with a goal to increase administration to six thousand doses per day. The state has contracted with true care. Twenty four to operate that site now among the community. Vaccinations sites that were previously previously opened. One two three four. They're five of them. That includes the ranch events complex in loveland. Which is a community vaccination site in partnership with fema police went on to say colorado wins ages seventy and older and to a lesser extent. Those sixty and older will continued to be prioritized in the vaccination process adding please. If you are over seventy we want to prioritize making sure you are safe because you in that age group you are at the highest risk For well the impacts of the virus he also announced that at this point percents of colorado and sixty and older have already been vaccinated that includes seventy nine percent of folks seventy and older seventy one percent of people ages sixty five to sixty nine and fifty three percent of people ages sixty to sixty four overall one million five hundred seventy nine thousand five hundred and ninety nine Have been vaccinated with a first dose and nine hundred ninety. nine thousand. Six hundred in eighteen have been fully vaccinated. This as a governor. Pull us announcing. The state is expecting the courts according to a piece out of nine news by wilson breeze The state is expecting vaccinations to expand to phase two on friday april second again including the general public colorado in sixteen and older eligible for the pfizer vaccine. Those eighteen and older will also be eligible for the moderna and johnson and johnson. Vaccines eight sixteen. Now thirteen ten. Kfi a thirteen ten kfi k. A. dot com this time check. Sponsored divided candlelight dinner playhouse in johnstown bringing you an amazing musical production of little women starting april eighth and running through june. Sixth all you have to do is jump online. Visit colorado candlelight dot com for tickets and show information. Candlelight dinner playhouse.

Johnson & Johnson one-shot COVID vaccine rolls out in the U.S.

Democracy Now! Audio

00:48 sec | Last month

Johnson & Johnson one-shot COVID vaccine rolls out in the U.S.

"And johnson's covid nineteen vaccine is starting to roll out across the united states after it received final approval of the centers for disease control unlike the two other approved vaccines in the us. Madeira and pfizer. Biontech johnson and johnson requires one shot and does not need to be stored in the freezer. This comes as health. Experts warn the recent decline in cases is slowing down as more states. Move to relax restrictions this is. Cdc director dr rachelle landscape. We may be done the virus but clearly the virus is not on with us. We cannot get comfortable or give in to a false sense of security that the worst of the pandemic is behind us not now not when mass vaccination that is so very

Biontech Johnson Johnson CDC Madeira Dr Rachelle United States Pfizer
Germany's rollout of Coronavirus vaccine is very slow

Monocle 24: The Briefing

00:39 sec | Last month

Germany's rollout of Coronavirus vaccine is very slow

"Modern times. Germany has basked in arguably earth's most flattering national stereotype that of a calm practical and orderly nation which just get stuff done without making thing that that reputation is being tested. If not outright joined by germany's bewilderingly. Sluggish rolled out of covid nineteen. Vaccines a sloth. Which seems all the stranger when it is recalled at one of the first vaccine which worked was developed in part by biontech a german company while germany's vaccine deployment is about power with the eu as a whole it is noticeable stretch behind for example that of the united kingdom

Germany EU United Kingdom
Johnson & Johnson COVID-19 vaccine deemed "safe and effective" by the FDA

Daily Coronavirus Update

07:10 min | Last month

Johnson & Johnson COVID-19 vaccine deemed "safe and effective" by the FDA

"And johnson. It's been shown that they're vaccine is effective at preventing hospitalizations and severe effects of covid. Nineteen this from scientists at the fda we're seeing about. I think it's sixty six percent effective when it comes to moderate to severe cases of covid nineteen so matthew. Tell a little bit more about what we're hearing with. His johnson and johnson vaccine right so what happened. Is that johnson. Johnson released data about a month ago. You know press release but the process for evaluating these vaccines is that they go through the fda and the fda really unique in the world independently looks at the data and re analyzes the data that the company produces and its own report and then hold a public meeting which will be happening friday and so the documents before the public meeting came out and they had some good news both some really clear data on hospitalizations and a general sense of approval from the fda researchers. Sometimes they're not as positive so it looks like this may be another option now. The big plus is on. This is one. It's a one shot dose. So you don't have to go back for a second jab in the arm and also doesn't need to be kept frozen like the pfizer derna vaccines do so shipping and handling of all of this will be a lot easier much easier to transport and that's a big advantage. It does not look like we're gonna have a huge amount of supply the start off with so it doesn't dramatically change how fast we're going to be any shots into people's arms but for a lot of people i think in a lot of experts i talked. You think this'll be a great option. It's one and done. I think some of the numbers. I saw the might have about four. That are produced right now. Ready to send out so it gets approved. They can get those out really quick but it wouldn't be until april possibly where they can really ramp up production to start distributing that right and will also be getting over that where they're hundreds of millions of doses of the two vaccines have the madonna and fayza biontech vaccines. That are expected to arrive in the us by july. So there's gonna be a lot more vaccine available. The jj supply will ramp up and we'll be getting more of those other two vaccines that leaves. There's a vaccine coming from nova vacs. We don't really know about how much will getting the early results issued press. Release again good and we're waiting for. Us results on the astra zeneca vaccine. Now some good news. With his johnson and johnson one is its effectiveness against these variants. That we've been hearing a lot about so it fared better than expected when it comes to those. I the way to interpret. That is we'd seen some results and the new results that they showed today look a bit better than what we'd seen in terms of variants. There's still does seem to be decreased. Efficacy against the south africa variant. Three five. Which is really the one that we're all worried about but it did look better than what we've seen previously and what j. j. has said it seems like with those variants. This vaccine is still preventing severe disease and hospitalization. Which are the key things. We've always wanted from vaccine here. The idea that you'd prevent a symptomatic infection or mild cases kind of bonus compared to just making sure that people end up in the hospital hospitalizations numbers were good on that front. What did we see when it comes to side effects. I saw that there were a few unexpected side effects. Although these are very rare you know but The expecting side effects the kind of pain in the arm the headache fatigue. That's pretty much in line with the other two vaccines. We have that right now. There were some rare events that occurred more often in the vaccine in the placebo group. Keeping in mind that forty thousand people were in this trial. There were fifteen serious blood clots including some. Dvd's in that exciting compared to ten in the placebo group. That's something the fda plans to monitor there was also some rini ears in the vaccine group and not in the placebo group. So that's kind of an odd one that will wanna watch again. This is really a prelude to friday win. Some of the top experts in the world are going to gather on zoom call and go over these data that the fda assembled we'll be live blogging that stat. That's when we really find out a lot about any medical product. It's it's one of the amazing things. The fda does now an interesting thing in all of this so public health officials might have a messaging problem when it comes to pumping the johnson and johnson. One out when we're seeing guys like pfizer maderna's say that their vaccine is ninety five percent effective against corona virus. Just listening to numbers right. This says sixty six percent. So what are they going to have a challenge in getting people to want to take this one over the other or you know how how to work out. It's really important to realize that particularly between those three vaccines. The getting vaccine is much better than not getting a vaccine. The change vaccine may be on par after a second dose and that study is being done but unlike visor during the second dose is going to be months after the first and then also slows down the study. She gotta wait right for people to get their second dose. So we're not expecting those data until kinda summerish but the big thing is for a lot of people. There was also the appeal of a single dose here. And i don't think we should understate that. And the effect on severe disease is big so the problem is gonna be the in the initial rollout. You really want people to take whatever vaccine. They're giving because being vaccinated is so much better than not being vaccinated. And that is part of the path to get in the world back to normal and public health. Authorities are absolutely going to have to articulate that now again because there's not going to be that much supply of this initially. They're going to have time for a learning curve right now. the demand for vaccines clearly outstrips supply. That's why you're hearing so many stories of people desperately logging on trying to get vaccine. What scott gottlieb used to run. The fda has raised the issue of you know. We're we're going to reach a point where the people who wanna get vaccinated we'll have been vaccinated and we're still going to need to vaccinate more people and that's when convincing people who are less sure to take vaccine in to take the vaccine that's available is going to become more of an issue last question briefly pfizer moderna vaccines are based on 'em a. What kind of platform is the johnson and johnson. When using this like theatrics annika vaccine is called an ad no virus which is a kind of virus that is used to the same kind of ideas marin a the instead of traditional vaccines were you inject the protein that your immune system sees and then learn to recognize an attack. These sneak something into your body that makes a lot of proteins. You make a lot more protein and then the body recognizes that an attack it in this case they're using this virus which is kind of a cold virus to sneak some genetic material in and that makes the spike protein from the sars virus which your body then learns to recognize and thereby has antibodies that attack the virus

Johnson FDA Astra Zeneca Pfizer Pfizer Maderna Matthew Nova Rini United States South Africa Headache Scott Gottlieb Marin Cold Virus
COVID-19 Pfizer Vaccines in U.K. Show Positive Results After One Dose

WSJ What's News

00:31 sec | Last month

COVID-19 Pfizer Vaccines in U.K. Show Positive Results After One Dose

"Data from the uk shows just a single dose of the pfizer. Biontech colbert nineteen vaccine can reduce infections. By more than half england's public health agency released the study which looked at infections in people eighty and older and showed a reduction of eighty eight percent after the second shot. According to the study the vaccine has also reduced hospitalizations and deaths. Today the uk outlined a plan to begin lifting lockdown restrictions. Next month schools will start reopening on march eighth and most other restrictions are expected to be lifted by the end of

Biontech Colbert Pfizer UK England
Pfizer says its COVID-19 vaccine can be stored safely in standard freezers

Heartland Newsfeed Radio Network

00:37 sec | Last month

Pfizer says its COVID-19 vaccine can be stored safely in standard freezers

"There could be a change in how one of the co vaccines is stored while remaining usable report suggests that pfizer in biontech virus vaccine may not require the hospital grade ultra low temperature. Storage sheds originally thought the is submitting new data to the fda demonstrating the vaccine remains stable when stored at temperatures as high as five degrees fahrenheit meeting. If the fda agrees with these findings the vaccine files could be stored up to two weeks in fraser's commonly found in regular pharmacies potentially expanding the vaccines reach into communities far away from major medical

Pfizer FDA Fraser
Israeli study finds Pfizer vaccine 85% effective after first shot

WSJ What's News

01:14 min | Last month

Israeli study finds Pfizer vaccine 85% effective after first shot

"A new study shows a single dose of pfizer and biotechs kobe. Nineteen vaccine is eighty five percent effective in preventing symptoms of disease. Fifteen to twenty eight days. After it's given the findings of the israeli study published in the lancet medical journal come as more countries way whether to delay doses. Our reporter blonde pinch. Husky has more that seems to vindicate. The decision made in the united kingdom. To delayed second does in order to vaccinate more people as quickly as possible. More and more evidence is mounting from similar studies that delaying the second does is a sound policy. And if this were to be proven without a doubt then basically countries like the united states would find themselves being able to practically double the number of people they vaccinate overnight visor and biontech still recommend that a second dose of their vaccine be administered twenty one days after the first separately the companies also said today that they're vaccine can be stored and transported in normal freezers rather than at ultra cold temperatures of between minus one. Hundred twelve and minus seventy six degrees fahrenheit which pose logistical challenges.

Lancet Medical Journal Pfizer United Kingdom United States
EU Decision on AstraZeneca's Covid-19 Vaccine Expected Today

WSJ What's News

04:52 min | 2 months ago

EU Decision on AstraZeneca's Covid-19 Vaccine Expected Today

"European regulators will decide today whether to approve the astrazeneca oxford corona virus vaccine for use in the eu. It's a big moment for the union. European countries have been lagging behind in their vaccination rollout compared to the uk and the us one of the reasons for that is the eu had ordered more doses of the astra zeneca vaccine the the pfizer biontech vaccine which was approved in december. They'd been hoping this new approval would get them up to speed but even before that happens there have been complications. Astrazeneca has told the e you it won't be able to fulfil its order right away and now more shortages could be on the horizon to discuss the situation. I'm joined now by the wall street. Journal's boy on panchev ski from berlin. Glad you're here boy on hi there mark boy on. Why is this shortage emerging. So what's happening is this. The european union doesn't seem to have ordered enough. Those is from the companies that kind of in the vaccine in the race to put a vaccine to market. And not only that but now it happens so that astrazeneca which developed a vaccine together with to oxford university seems to have had a problem in its supply chain and it saying econ deliver the original amount does is there were promised for for the first quarter of this year and these two things together have basically created a lack of supply for the european union. And now they are simply not enough shots for for all the people that need to receive them boy on. What is the response from astra zeneca. We heard from an e you commissioner. Recently who expressed tremendous dissatisfaction. Yes well there has been actually a bit of a war of words between the european union national governments and the european commission which which speaks for the european union and on one side and astra astrazeneca the pharmaceutical giant on the other astrazeneca denies that dave violated contractual obligations. They're saying they would been deliver. What they are meant to be delivering. But they have a bit of a hiccup related to a contractor in belgium and therefore they won't be able to meet the target but they're not saying that they are breaking commitments in law and that's the debate between the two sides. The you saying you know you. You've said you'll do this. You have an obligation to do that. The contract we haven't seen it is not public It's confidential and there has been talk now that the contract would be published so we can all see what's actually written in the contract and who is actually honoring mets or not. Can you way the company kind of rejects the european byu. That is done something wrong. Essentially and they're basically in a nutshell saying this is a normal part of this. This huge complex effort to produce hundreds of millions dozes for the whole world in in a ongoing pandemic boy on as that discussion is taking place. What's happening across europe to deal with this well essentially. There's a bit of a political backlash now in some countries of the european union notably in the most populous country germany because it has become apparent that there are not enough those this of vaccines of any kinds against coronavirus in the immediate term and that essentially means that people will who are vulnerable will not be able to be To get the job and be protected he immediately and that means also that the lockdowns were might be prolonged that the restrictions and the measures that we have in place in europe will will loss longer than people have perhaps hope for. There's so much they can do. Essentially what they could do is they could order more dozes from the companies. That have a vaccine that has been authorized by regulators. And so far we've got. As of friday. Essentially three companies astrazeneca is most likely to be authorized in europe. Then we have pfizer and biontech and we have modern. So what the the choice for the european union's toward more is now the problem with that. Is that everyone's those so you if you whoever orders now will be at the back of the queue. there's global q. Of nations or waiting for supplies and and some of them are huge. Markets such as the united states such as great britain and in the case of zenica india. And so on. So that won't be easy and and there will be slight delay in delivering. Whatever new orders might might be placed

Astrazeneca European Union Astrazeneca Oxford Mark Boy Astra European Union National Govern Pfizer Oxford University Berlin European Commission UK Belgium United States Europe Dave Mets Germany Zenica Great Britain India
Vials and tribulations: the EUs vaccine push

The Economist: The Intelligence

02:29 min | 2 months ago

Vials and tribulations: the EUs vaccine push

"The likes of. America and britain are racing ahead with vaccine programs. Most of the twenty-seven member states of the european union have barely left the starting blocks by last week the you had vaccinated one point four percent of its population. in britain. It was seven percent in america. Five and after that sluggish start the block. Looks like it'll be further hampered by cut to supply astrazeneca and pfizer biontech of both said production problems go preclude them from meeting. The expected numbers the eu says. It will tighten export controls and threatening legal action. The president of the european commission ursula von der lion urged the companies to meet their promises invested billions to help develop the world's first covid nineteen vaccines to create a truly global common. Good and now the companies must deliver. They must honor. The obligations. Astrazeneca has defended its efforts partly blaming the eu for delays in signing the contract the eu for its part hasn't yet approved the astrazeneca vaccine. That's expected to happen on friday a month. Behind britain the european commission had set a goal of inoculating seventy percent of europe's adults by the summer. It's a target that looks increasingly unlikely. I think the best way to describe how europe is progressing with the fact. Saination program is radically sophie. Petr is our paris bureau chief. Each european country has delegated all the buying the distribution of vaccines and the authorization for them to european authorities which means that each country ought to be at the same point. But if you actually look at what's happening on the ground that's not. The case is a very patchy pitcher. Then why is that. When you're dealing with twenty seven different health systems and health is something that is not managed at european level it manage country each of those systems different. They tend to be quite centralized. In some cases you take france be good example or centralized as in germany and each system has its benefits in some cases during the early months of the pandemic last year. It was actually thought to helped. Germany's have such a decentralized system. But now germany's steams be finding it difficult to get out the vaccine like disadvantage so it really is this patchwork of different health systems and different campaigns that i think explains the differences across the continent

Astrazeneca European Union Britain Ursula Von Der Lion European Commission America Pfizer Europe Petr Sophie Paris Germany France
European Union Warns AstraZeneca Over Reduction In Vaccine Shipments

Monocle 24: Midori House

01:36 min | 2 months ago

European Union Warns AstraZeneca Over Reduction In Vaccine Shipments

"Let's start with an argument. That's being brewing between the european union and with nineteen vaccine suppliers after astrazeneca and pfizer biontech. Both set production problems mean they cannot supply the expect at numbers the eu has now wants the producers. they must deliver create vaccine supplies. There are fears that reductions scoot seriously. Slow down the vaccine. Rollout in the union gwendolyn peel. Who used to be the financial times correspondent in berlin gave us. He's view on this arguments. Sent the eu has got. I think a real political problem. They have clearly been slower in ordering in advance enough vaccines to get that population vaccinated in good time. They're way behind both the us and the uk who spent about seven times more up front than the e you did. And i think the truth is that the uk and the us showed they were prepared to cut corners and the eu has been terribly bureaucratic about the whole thing. So that's one of the problems they've got to deal with and it's ironic. Because of course. The very first vaccine was developed developed in germany and being exploited in the us. But we are talking about in manufacturing terms a huge operation to get the sheer quantity of stuff produced. And i think that's what we're seeing now. We're seeing that the actress producing these vaccines a really struggling to manage the

EU Astrazeneca Pfizer Berlin UK United States Germany
Why will most Australians get a less effective vaccine?

Coronacast

06:13 min | 3 months ago

Why will most Australians get a less effective vaccine?

"Australia's on track to get access to or to approve two different coronavirus. Vaccines is one from fayza. Biontech and there's one from oxford strelka but the two vaccines are quite different defies. A shot has like ninety five percent efficacy based on the studies and the oxford. One has a lot less than that. But it looks like we're only gonna get enough of the fiso one to vaccinate maybe five million people it's going to be prioritized for the people who are most vulnerable kind of everyone else is gonna get the oxford one. So we've got simony questions from people and a lot of them. Cluster around the question of why most australians going to get a vaccine that looks a lot less impressive than what we know is possible when it comes to fighting corona virus country. I just wanted to chain. Just want to alter one thing that you say. Is that the head of the therapeutic goods administration before christmas indicated that in fact they were going to get data from johnson and johnson from their vaccine. So this is not one of the vaccines that the government's got an arrangement with but i think they've made a preliminary application and all the last forty eight hours. The ceo of johnson. Johnson has said that they're going to be releasing their phase three trial data in the very near future. Now this is an adenovirus vaccine which is one which called virus. If you'd like carries the corona virus spike into the cell. A bit like the astro vaccine and the chinese vaccines. But it's a one dose vaccine rather than a two doors vaccine so really interesting vaccine. It'll be really interesting to see what they come up with this. This the johnson and johnson one and we'll possibly be another option. The tj seemed to save before christmas that this was on the table for approval which is interesting even though we haven't got a business arrangement with them as far as we are led to believe. Okay so let's just recap on the data the pfizer the moderna and the astro vaccines all do the same thing. They take genetic messages into the cell and tell the cell to produce the spike protein which then goes off into the blood and the immune system responds and create an immune reaction which is then memorized for future infections the pfizer and moderna one dude by mini which package of genetic messaging and the astra. One does it with a chimpanzee virus. Adenoviruses takes into the cell and leaves the genetic message there behind to produce the spike protein. So they do the same thing but in different ways from the trials the phaser moderna vaccines have you around. About ninety five percent efficacy. Let me just explain. The word efficacy for a moment. Efficacy is a word used in trials clinical trials which shows the in the trial context in the circumstances of that trial where the included and excluded certain people and the duration of what they monitored. That's really what efficacy means. Within the context of trial they got ninety. Five percent efficacy at reducing disease. If you were infected there were not enough data from those two trials at least not yet to show whether the affected infection and transmission although with the astra trial they did actually have datta which did suggest that the astra vaccine prevents transmission. Which makes us pretty confident that the pfizer. We'll actually resist transmission tube but we have no data on that yet. So it's efficacy. It's not effectiveness in the real world so when you introduce a vaccine or a drug into the real world. The efficacy may change. It may go down. It may go up and that will be seen as we monitor it going through. Okay so what did the astro vaccine find it. Find that when you gave to standard dozes roundabout four weeks apart thereabouts. You got sixty two percent effectiveness at reducing disease all disease and much harder effectiveness reducing severe disease so all these vaccines seemed really good at preventing severe disease and death but the oxford overall sixty two percent effective. The seventy two percent comes from an average and really shouldn't be used because it's not relevant average because the smaller british trial made an error and gave a smaller dose to some people who raised under fifty five and then give a standard does later and what they got was ninety percent effectiveness in that small. Subgroup wasn't planned but they noticed there and when they put those two together. That's got seventy percents so it's not a fair comparison. Comparing standard does to standards to those standards especially younger people might be less likely to have severe disease anyway. Yes so that makes sense biologically because what's happening. Almost certainly with the astro vaccine is that the body is developing antibodies. Nobody absolutely proven. But it's actually ironically and sort of sadly developing antibodies to the chimpanzee admiral virus so the very virus that's like an uber bringing the genetic basis into the cell. The body's reacting to that so when you get the second does the second dose isn't working as well because the body's working against the actual vaccine vaccinated against the vaccine so that makes sense with the low dose because you haven't generated as many antibodies to the chimpanzee virus there for you get a really good prime with the first low does and then a good hit with a second does now there's indications that came out of the same is true of india and a sense from the ceo of astra that the results are better than you think. And the implication was that if you separate the two standard doses by three months you might get sent effectiveness now. We talked about it a little bit but that on yesterday's corona cast 'cause that's a long time between dozes and as we've seen just talking about the uk variant. We talked about the brazilian various african very very unfair to them by country. But that's the shorthand version of doing it. We're getting a quite quickly of new variants and three months between vaccines might be too long and that the virus changes between dozes and. That's the problem there.

Johnson Oxford Astra Pfizer Therapeutic Goods Administrati Moderna Severe Disease Australia Government India UK
Israel leads vaccine race with 12% given jab

Monocle 24: The Briefing

04:55 min | 3 months ago

Israel leads vaccine race with 12% given jab

"Bleak though the covid nineteen news is on a number of fronts. There is mercifully tunnel. Luminated light in the form of several vaccines becoming more and more available and a race of sorts is on countries which can vaccinate their populations. Fastest will aside from doing. Obviously the right thing themselves. A considerable competitive advantage in terms of reopening at home and potentially reengaging with the world leading the field by a stretch is israel more than a million israelis over a tenth of the population have already received the first shot of the to phase pfizer. Biontech job one joint first of all by alison kaplan some journalist with herod's alison. Obviously israel has certain natural advantages. Here i it is only nine million or so people living in quad small geographic area but that aside. What is israel secret. How is it done it so quickly. Well i think we've got a very lucky combination of two factors number. One is the hustle of prime minister. Benjamin netanyahu who you know he's been around for a very long time developed a lot of connections in in many places and he made it a priority. I think to line up very early. Orders of A vaccine from multiple companies sort of placing his bets while widely and And putting a lot of pressure on the On the heads of the companies. And i think he you know. He carries a lot of weight. 'cause he's because he's a very well known world figure but i think that you can't give the credit to netanyahu because the way that the israeli healthcare system is set up is. It's a public health system but it's also highly competitive. We have four or five very large. Hmo's each with their own staff each with their own infrastructure who are set up every season to give multiple flu vaccines and basically what the country has done his taken these multiple. Hmo's and for the covid. Vaccinations put them on steroids. And they were very early and very well organized to and they're all very digitized so everyone's just getting a text message on their phone over-sixties in high risk people right now. I'm telling them to To go online and sign up. They can do that. They can do by phone if they want. So it's really a winning combination of netanyahu's hustle and and the way that the israeli healthcare system is very efficient and effective. Is this also one of those moments. At which and. I'm reminded here of a conversation we had earlier in the with. Joseph woo foreign minister of taiwan. Who made the point that his is a country which like israel is also accustomed to collectively responding and mobilizing in times of crisis. Is there something to that. Absolutely no listen. They don't call it the six day war for nothing right. The the country knows how do How to scramble and get a lot done. In in short amounts of time now the other side of the coin paint too rosy picture of the situation in israel because we are making amazing progress and vaccinations. But we've had some terrible terrible trouble of enforcing the restrictions for the coronavirus virus to keep people safe in our infection rate while we've been able to keep deaths down again. Excellent healthcare system has not been so successful. Israelis are very good at doing things. But they're not so good at not doing things. And so the whole social distancing and keeping things closed has not been a huge success here and tanio as much as he may be. The hero of the vaccine. Effort is is having to handle a lot of very harsh criticism about how the government has not effectively managed. The crisis is any talk at all of extending. This rolled out to the palestinian territories. As for now right now know. There are some clauses in the oslo accords of the mid nineties. I think that specifically refers to vaccines that gives the palestinian authority atonomy over vaccinating the palestinian population and they've even been some palestinian officials. That said we haven't asked israel to help us with with vaccines going to go our own way. That said i think that once israel really feels that it's got its population in hand and israel is not a sort of going to head to the finish line. There's going to be a hold up in january because israel does not have sufficient orders ship for delivery in january but once israel does feel secure about getting its population of vaccinated. I think that it's going to extend some sort of assistance to Certainly the west bank because the populations are mixed and so having a lot of covid in carriers among the palestinian population. Israel has a self interest in doing something about that but until now nothing has happened. Alison haaretz thank you for joining us.

Israel Alison Kaplan HMO Netanyahu Joseph Woo Benjamin Netanyahu Herod Pfizer Alison Tanio FLU Taiwan Palestinian Authority Oslo Government West Bank Alison Haaretz
Germany, Hungary give 1st vaccine shots ahead of EU rollout

NPR News Now

00:40 sec | 3 months ago

Germany, Hungary give 1st vaccine shots ahead of EU rollout

"Twenty-seven member european union had originally planned for national authorities to administer the first covid vaccine shots in a coordinated effort tomorrow but now germany has joined hungry in jumping the day of the e. u.'s planned release of the pfizer. Biontech shot starting today. Hungarian doctors and other workers in the health sector have begun getting vaccinated with the first shipment of doses and the operator of a nursing home in germany where the first shots were given to dozens of people said that quote every day. We wait is one day too. Many over three hundred thirty six hundred deaths have been linked to covid nineteen in europe.

Biontech European Union Germany Pfizer Europe
BioNTech CEO says Covid vaccine could be adjusted for mutations

NBC Nightly News

00:46 sec | 3 months ago

BioNTech CEO says Covid vaccine could be adjusted for mutations

"The ceo of pfizer's german partner said today he is confident. Vaccine is effective against the new strain. That has much of the uk on lockdown. It's encouraging news. It's one of britain's top. Medical advisors warned. The new strain is likely already here in the us. He spoke to our richard angle a year into the pandemic the corona virus showing its power as a shape shifter but today the ceo of biontech the inventor of the pfizer vaccine said. The vaccine could be adjusted for mutations in principle. Technically it is possible to make a new vaccine mimicking the news. A few weeks british virologists estimate the new viral strain is forty to fifty percent more

Pfizer Richard Angle Biontech Britain UK United States
BioNTech CEO confident vaccine will work on UK variant

AP News Radio

00:43 sec | 4 months ago

BioNTech CEO confident vaccine will work on UK variant

"German pharmaceutical company by Intex chief executive says he's confident that it's a coronavirus vaccine it works against the new U. K. variant but further studies are needed to be completely shore the variants detected mainly in London and the south east of England in recent weeks has sparked concern worldwide because of signs that he may spread more easily while there's no indication it causes more serious illness numerous countries in Europe and beyond have restricted travel from the U. K. as a result good science says he doesn't know if the vaccine is able to provide protection against this new variant but scientifically it's highly likely that the immune response by this vaccine can also deal with the new virus variants I'm sorry a shockingly

Intex U. South East England London Europe
"biontech" Discussed on Here & Now

Here & Now

06:55 min | 4 months ago

"biontech" Discussed on Here & Now

"Thanks to you. let's get to the knees a from. Npr wb you are. I'm robin young. I'm peter o'dowd this is here now in this next story is a reminder that sometimes truth is stranger than fiction a russian spy unwittingly revealed how russian agents nearly killed opposition leader alexei. Navalny back in august. When they placed the lethal agent novichok inside navales underpants even stranger the spy disclose that detail. Tuna vanni himself who was impersonating a high ranking russian official on the phone. Cnn's claris award broke this story in collaboration with the investigative outlet. Belling cat and dir sh- beagle and she joins us via skype clarisa. Welcome thank you so much for having me on peter. We'll start with a little more context here back in august. Vanni was flying to moscow from the city of tomsk when he became very ill on the airplane and here he is recounting that moment to you. Let's listen. I get out of this bathroom john over to the flight attendant and said i was poisoned. I'm going to die life. And then then. I laid down his feet and to to die so the pilot then diverted the plane to the russian city of omsk navan survived. He's now in germany. But tell us what you learned about the days and hours leading up to that moment on the airplane. I mean you know. It's just been extraordinary to get this kind of insight into how an elite team of fsb russian state security service operatives with a specialty in chemical weapons many of them doctors scientists operating out of a unremarkable moscow suburb were able to essentially trail navales every move for more than three years. Then as you said in august nova only became very sick on the way back from tomsk on this flight and the germans whence he was able to be transported to germany confirmed that he had been poisoned with novichok. We now know that navy chalk was planted in navan. These underpants can believe that. What does that detail say to you. So we spoke to a lot of experts about this to try to understand it better both from the point of view of understanding whether the intention was to kill or possibly just to incapacitate and by the way all of them agree. You can only really be looking to kill. When you're using nabi chalk outside of labar trae but also to get a better sense of why would they put nava jock. In the underpants and particularly this one operative describes in this now famous phone call to alexei navalny were nevada was posing as a senior national security aide. conducting an investigation into the operation. He tells him listen. We put it on the underwear on the inside. Seams of the crotch area and experts have told us that the groin area is particularly porous particularly susceptible to this kind of poisoning. So they certainly knew what they were doing it as you say it was not only himself who was able to coax these details out of this agent who is a part of this toxins team. Why didn't have only do that. How did nevada do that. So when i was in moscow last week with my team we all said about trying to confront some of the people that through this investigation with belling cat. We have been able to identify as part of this. Fsp toxins team. Then they landed on this idea of pretending to be someone high up within the russian hierarchy and they were able to disguise the phone number they were using to make it look like they were calling from an fsb landline. And if you listen to the conversation it's something like forty five minutes long. It does take a while to persuade this operative. His name is constantine could derisive he graduated from the russian academy of chemical defense. It does take him a while to be persuaded that it's okay for him to have this conversation on an open line with only but once he starts talking boy does he start talking. Vladimir putin himself has said that if his agents wanted to kill vanni they would have done it. So what do you make of that reaction in russia. About how high up. This operation went in the government. Well this puts the kremlin in an extraordinarily embarrassing and uncomfortable position because just last week president putin responding to our reporting said. What's the big deal. So what the. Fsp were following navalny. That's normal because he works with. Us intelligence services that doesn't mean they poisoned him. Well fast forward just a few days and here. We are with concrete evidence that in fact that team of operatives who were falling him did poison him. And so how on earth does the kremlin go about Wriggling out of this one. Essentially i will say that unlike last week where it was much more silent and the russian media and people weren't really talking about perhaps because they were fearful this time people are starting to talk about it. We've already seen russian journalists trying to go to the address of threats up this operative who unwittingly Confessed to alexei navalny. And i think it's going to be very difficult for the russian government to put this genie back in the bottle and just briefly clarify. It is amazing to see you sitting there in front of alexei. Navalny who had gone through such a tremendously traumatic ordeal on this airplane getting poisoned. He's been a thorn in the side of let him. You're putin for many years. It's amazing that he's still alive. How is his health. How's he doing. He has made nothing short of miraculous recovery and all of his doctors say the same thing what is even more extraordinary. Is that alexei. Navalny is still planning to go back to russia. He says he's a russian politician. He belongs in russia and he would never give putin such a gift. He said as to stay outside of his country. Cnn's clears award reported the story along with the investigative outlet. Belen cat and dir spiegel in germany. Clarisa thank you so much. Thank you quite something. Let's get the latest on corona virus vaccines today. The european union gave the green light to the pfizer and biontech covid nineteen vaccine already in use in the. Us and americans are expected to start receiving an additional vaccine from derna so far in the us the only people to get vaccinated outside of clinical trials have been prominent politicians health care workers and some residents of long term care facilities but yesterday the cdc panel recommended that americans at least seventy five years old and frontline essential workers. Be next in line to. Let's take a look with dr hamish. Adult a senior scholar at the johns hopkins says for health and security dr dodger. Welcome.

Navalny tomsk robin young peter o Tuna vanni navan alexei navalny moscow alexei nabi chalk labar trae nava jock Vanni germany dowd omsk nevada president putin Npr russian academy of chemical de
"biontech" Discussed on Heartland Newsfeed Radio Network

Heartland Newsfeed Radio Network

04:50 min | 4 months ago

"biontech" Discussed on Heartland Newsfeed Radio Network

"The top of the page and type in fox distribution efforts already starting. I'm joe chiro fox news. Maderna's newly approved covid nineteen vaccines expected to begin shipping with a rival destinations on monday. General gustav purna who leads operation. Warp speed says efforts have already begun. Boxes are being packed and loaded today. Trucks will begin rolling out tomorrow from fedex and ups delivering vaccines and kits. To the american people. Across the united states. Spur necessa medina vaccine will be shipped to about thirty seven hundred locations across the country. Congress holding a rare weekend session finalized negotiations on a corona virus stimulus. Bill they hope to forge a deal on the kovic bill today but that has not happened yet. The hold up is a provision push by republican pennsylvania. Senator pat toomey. Democrats say to planned prevents the federal reserve from providing emergency help during the pandemic to me once restrictions for the fed. We've never asked the fed to engage in fiscal policy or promote social policy or to credit based on political standing to me talked with federal reserve chairman jerome powell. He also met with senate democratic leader. Chuck schumer in an effort to resolve the dispute boxes. Chad pergram more. Republicans are calling for a special counsel investigation into hundred biden and his overseas business dealings. Other republicans are worried that the us attorney in delaware who is leading the investigation. David weiss might feel pressure from the soon to be president and fellow delaware resident. Joe biden congressman. Andy biggs telling the washington times today this quote if there was a shift in administrations do you think wife and his subordinate would risk advancement by taking down the president's son and brother and anyone else who may be implicated hillary von reporting from wilmington. America is listening fox news. Don't let the smart speaker be the only smart one in the room instead of binging on mindless entertainment. Or letting the news. Get your blood pressure up. Feed your brain of curiosity stream. Curiosity stream has been called the net flicks for documentaries with on demand. Access to thousands of documentaries award-winning exclusives and original programs. For just twenty dollars a year you can get smarter. Entertainment a curiosity stream dot com watch anywhere on any device and cancel anytime whether it's roman armor or convective cooking they go deep on all subjects with nonfiction shows like amazing dino world pompeii disaster street and the history of home with nick offerman and with curiosity stream. Your good company. It was launched by discovery. Channel creator jon hendricks and has over thirteen million subscribers worldwide. Join them right now. For a limited time get twenty five percent off when you sign up a curiosity stream dot com slash fox curiosity stream dot com slash fox for twenty five percent off curiosity stream dot com slash fox. Israel's prime minister has been vaccinated against the current virus. The shot prime minister. Benjamin netanyahu received today made him the first israeli and among the world's first leaders to be inoculated. He received the injection of the pfizer biontech vaccine at the sheba medical center near tel aviv. More businesses are having to lay off employees in the wake of corona virus restrictions. Thirteen percent of small businesses are saying that they will need to lay off staff that from nine percent in july and september really showing that more businesses are really needing to make these cuts. We know in san diego california back and forth over a ruling there after a ruling that strip clubs serving food could still operate a judge then ruled that restaurants could also remain open and that is despite governor gavin. Newsom stay at home orders well yesterday. An appeals court blocked the judges call in minnesota after a four week. Pause governor tim wolf's loosen restrictions now allowing dining to resume outside at fifty percent capacity. Indoor dining is still off the table there until january. eleven hogan wanted a kidney donor. Fox's karen mchugh has a unique story of giving mark winer of new york's long island needs a kidney so a couple of years ago. He put his face and contact involved at times square. Billboard michael low low in new york city cop responded those two were not a match but then lolo heard about a total stranger who was two years ago. Sixty two year old ruth t sack one. Of lola's kidneys. That started the generous chain of events t sacks husband. Paul gave one of his kidneys to someone. He didn't know an online platform. Called the national kidney registry has facilitated more than four thousand living donations like these but.

federal reserve joe chiro Maderna General gustav purna Senator pat toomey jerome powell Chad pergram fox news Andy biggs delaware united states David weiss nick offerman Chuck schumer jon hendricks fox fedex the washington times Joe biden
How the Moderna vaccine stacks up against Pfizer/BioNTech

Dave Ramsey

00:36 sec | 4 months ago

How the Moderna vaccine stacks up against Pfizer/BioNTech

"Monday across the nation after receiving emergency FDA authorization on Friday. Operation Warp Speed leader General Gustav Pernas says the Moderna vaccine has one advantage over fighters. Madonna vaccine can be shipped and stored at standard freezer temperatures. And is packed in containers of 100 doses each. This allows jurisdictions the flexibility to support hard to reach small and Maura rural areas, furnaces and modern a vaccine will be distributed to about 3700. U. S locations lawmakers around Capitol Hill

Gustav Pernas FDA Madonna Capitol Hill
"biontech" Discussed on WSJ What's News

WSJ What's News

01:54 min | 4 months ago

"biontech" Discussed on WSJ What's News

"Maderna's vaccine uses the same. Arnie gene technology as pfizer and biontech. A significant difference. Here is that it doesn't need to be stored at ultra cold temperatures peter. How will that impact the logistical efforts involved in shipping and distributing these vaccines. It will impact them because it will shape which destinations receive which vaccine so the pfizer vaccine. Yes it does have to be stored at ultra cold. Temperatures and another factor. Is that the minimum order size for the pfizer. Vaccine is nine hundred seventy five doses and so this makes it more suitable so to speak for say a larger has system that will be able to use up those doses relatively quickly whereas the moderna vaccine can be stored at higher temperatures. Still cold still frozen during shipment. But it doesn't require the specialized freezers or dry. Ice like the pfizer vaccine and it comes in smaller order sizes and so that could make it easier to get out to smaller hospitals in rural areas. How does the efficacy of maderas vaccine compared to that of pfizer and biontech specs. Seen the very comparable visors vaccine was shown to be about ninety five percent effective in a big clinical trial meaning that it protected the vast majority of people against covid nineteen disease with certain symptoms and then maderna's vaccine was about ninety four percent effective a separate trial but very much in the same ballpark. What about potential side effects from taking the maderno vaccine are they comparable to what we've seen in the pfizer biontech vaccine.

pfizer Maderna Arnie gene technology biontech maderna
"biontech" Discussed on Rocketship.fm

Rocketship.fm

04:06 min | 4 months ago

"biontech" Discussed on Rocketship.fm

"Virus vaccine full supply and now task is to make use of the fruits of this endeavour to save lives and then about ten days later the us announced its approval of the pfizer vaccine. I am pleased to announce that late yesterday. The fda authorized for emergency use the pfizer bio covid nineteen vaccine. This is the first covid. Nineteen vaccine to be authorized in the united states. The fda is respected worldwide and is considered the gold standard regulator of medical products. We applied our high standards of review in reviewing this product so that americans can have trust and confidence that the vaccine meets fda rigorous standards for safety and effectiveness and with this authorization. We know that our federal partners are already moving to distribute the first doses of the vaccine throughout the country and now the country gets ready to distribute the vaccine to millions of people. Hey good morning. Martha you could argue. This moment has been nine months in the making. Take a look at the loading dock behind me here just moments ago. We saw some of the first trucks loaded up with the vaccine. Leaving this doc. It's a huge step. That could help to eventually get the pandemic under control now. I want you to take a look at some of these images after getting that emergency use authorization from the fda the vials filled with the life saving vaccine began their journey from the pfizer facility. Here states across the country now from ultra cold freezers to specially designed boxes to keep those cold temperatures. Each box can hold about five thousand doses. Now the boxes are then loaded onto trucks taking that precious cargo to area airports. Now this initial batch of the vaccine consists of some two point. Nine million doses. Us marshals as this their martha were escorting those trucks as they head to the airports pfizer says they will be working twenty four seven until they get that entire first batch out of here martha. Thanks so much alex. Let's bring in chief. National affairs correspondent. Tom yomas who is covered the cova crisis across the country from day one. Tom walk us through what happens next. It's absolutely incredible. Hailed as the dream team to digit and shy in the vaccine will get the green light from regulators of this month so they can start producing up to one point. Three billion dozes in collaboration with pharmaceutical giant pfizer. By the end of next year the turkish german couple say they will price the vaccine below market rates to ensure everyone gets access so that brings us to the end of this part of the journey. And they're still countless logistical challenges. The team faces and distributing billions of doses to people worldwide. But we're thankful for the spirit of earl shine newsham turkish and the numerous other scientists who have been working around the clock since january to develop this vaccine. Yeah into all the frontline workers who have helped us through this trying time working overtime to save as many lives as they can. I mean i'm sure we all know them. My step mom's one of them actually and Yet just a big goes out to all of them absolutely. It's everyone has done their part wearing a mask social distancing we thank you thanks so much for listening to rocketship dot. Fm rocketship fm now as a premium ad free. All you have to do is go to below dot com forward slash rocket ship and subscribe and help support show and the gives you an ad free experience to actually get an exclusive that you can listen to on i tunes or wherever you listen to your podcasts. Yeah and rocket. Fm is produced in partnership with product. Which is a community. For software product product collective is also the home of industry the product conference industry virtual workshops on one of the largest slack groups for product people. And we're also on the pod glummer network so a huge thanks pod glamour. You can listen to all the pot. Garments shows at the pod. Kilometers dot com. We'll see you again next week rocket ship..

pfizer fda pfizer facility Tom yomas us Tom walk martha Martha earl shine newsham alex
"biontech" Discussed on Rocketship.fm

Rocketship.fm

07:44 min | 4 months ago

"biontech" Discussed on Rocketship.fm

"Support for this podcast comes from we work. Today takes new ways of working new measures toward health and safety flexible terms to scale up and down convenience spaces designed for focus and collaboration. It takes we work to take your business where you want to go we work. That's tomorrow works. Visit we work. Dot com slash. Tomorrow this episode is brought to you by digital ocean app platform a new platform as a service solution to build modern cloud native apps with app platform. You can build. Deploy in scale apps and static websites quickly and easily get started for free at due. Dot co forward slash rocketship. That's do dot co slash rocketship support for this podcast comes from goldman sachs through launch with gs a five hundred million dollar investment strategy grounded in the belief that teams with diverse leadership drives stronger returns goldman sachs remains committed to facilitating connections and increasing access to capital for women black. Latino ex and other diverse entrepreneurs learn more at gs dot com slash launch g. S so this week celebrated the approval of what is largely being dubbed the pfizer cove in nineteen vaccine in the uk and the united states and canada. But did you know that the actual vaccine candidate was developed inside of pfizer facility. Really cause most of the news. I watch like this as we come on the air this morning history is being made the fastest development production and distribution of a vaccine ever in this country. Ten months after the lockdowns began this morning. We have something we have not had enough of this year. Hope you're looking at pfizer's main vaccine manufacturing facility in kalamazoo michigan this morning where those vaccines will be loaded onto. Fedex and ups trucks fanning out across the nation. Just the starting point in a massive operation right pfizer shipping the first vaccine pfizer manufacturing doses of the vaccine but in reality pfizer was more like a record label right helping to invest in and develop an artist rather than the creative genius behind the music. Okay yes it would be is if the headlines read republic records releases surprise album evermore instead of you know taylor swift right exactly okay. So who is that creative genius in this metaphor. it's the husband wife team behind the company bio on tech or bio attack in an interview. The you didn't really care pronounce the name but this team had never released a vaccine before let alone on a global scale interesting okay. So i'm guessing today we're going to learn who's buying the company bio intech and how that now infamous partnership with pfizer was developed absolutely while we usually discuss software companies. This was a fascinating timely story about product in this case a vaccine that brought in hundreds of millions of dollars for this fifteen hundred person german company as part of a global race for a cure to the covid. Nineteen pandemic mike. It's trump all right. Here we go. Welcome to rocketship dot. Fm racket chip fm is produced in partnership with product collective. We are your hosts. Michael sokha and mike bell saito. So in december of two thousand and nineteen word began spreading in the scientific community about new clusters of pneumonia cases. Here's jason mclean. A krona virus researcher from the university of from an interview with joe hansen on pbs. At the end of december two thousand and nineteen. It was on the news. Is these pneumonia clusters in china in the community. We thought maybe the new flu virus or possibly a colonel virus. I was actually snowboarding with my family. And my collaborator barney. Graham at the vaccine research center at the nih call and he said he's been in contact with us. Cdc chinese cdc. It looks like it's a beta coronavirus similar to sars and they wanted to move rapidly trying to make a vaccine and i said we're definitely in so you're just like scrolling through your phone in this key lodge really gotta get to work. Researchers in china decoded the virus genome and the world health organization published online on january tenth of twenty twenty essentially starting the race for a vaccine and this was still months before the world was actually locked down years. Cnbc segment from january thirtieth of this year meantime. The world health organization holds an emergency meeting today to determine whether to clare a public health. Emergency regarding the coronavirus. Here's what we know. So far chinese officials say the death tolls risen to one seventy seventy nine hundred cases worldwide and the number of cases in china surpasses the total cases. During the sars epidemic of over three meantime the president appoints and meets with the coronavirus taskforce yesterday said to me daily to discuss ongoing developments both domestic and overseas joining us. Now is the head of that task force. Us health and human services secretary. Alex as mister secretary. Good morning good to have you with us. Glad to be with you all. Thank you very much you said when you announce the task force that the risk of infection for americans remains low will that assessment change if world health does declare emergency. No it what the world health organization does in terms of declaring whether there's a public health emergency of international consequence won't change in any way what we're doing here in the united states to prepare and respond to the novel corona virus threat as you mentioned the threat to any individual. American is really quite low at this time but under president trump's direction where proactively preparing in the event of further spread and we're taking necessary steps to prevent and mitigate the potential for future spread. We've seen a lot of selective flight restrictions from the airlines themselves what would it take to mandate flight restrictions. Well we're not gonna take any public health options off the table to protect the american public. This is actually more alarming than i remember at the time but we were watching it at really kind of from afar at this point Luckily the scientific community they were already working on a solution and one of those companies was biotech founded by or shine and uis lem church and christopher hoover huber is an international leader in the field of immuno oncology and shine and Are husband and wife team. Both turkish migrants to germany who have dedicated themselves to cancer. Research bio and tech was founded in mainz germany in two thousand eight based on initial research from the trio which focused on the development and production of technologies and drugs for individualized cancer immunotherapy in normal times bio and tech. And it's roughly fifteen hundred. Employees are focused on developing those specialized immuno therapies for cancer patients. Based on messenger are in a or m ornate which are molecules that trigger the building of proteins in cells to stimulate the immune system. Now the scientific world moves much lower than tech the company made a couple of acquisitions in two thousand nine most likely to consolidate key talent between twenty fourteen and twenty eighteen research results. on 'em are mechanisms were published during this period. Biontech filed several patent applications developed a multilayered strategy to protect its intellectual property in the various technology platforms and their application in the treatment of cancer and other serious diseases. But this is also key because this is when pfizer and biotech signed did initial agreement entering into a multi year research and development collaboration to develop m. r. n. a. based vaccines for the prevention of influenza. Or the flu. So let's get into the weeds a little bit here first off. What does the vaccine actually do. Simplest explanation i could find. Is that it. Trains your to learn. What a specific virus and looks like an.

pfizer Dot co goldman sachs pfizer cove world health organization Michael sokha mike bell saito jason mclean university of from joe hansen vaccine research center pneumonia Cdc china kalamazoo taylor swift Fedex united states president trump
Pfizer-BioNTech vaccine may be administered in just days after FDA authorization

Heartland Newsfeed Radio Network

00:44 sec | 4 months ago

Pfizer-BioNTech vaccine may be administered in just days after FDA authorization

"Fda giving the okay for americans to be inoculated against the corona virus the approval for pfizer in biontech samora vaccine against the coronavirus comes in the form of what the agency calls in emergency use authorization the eu as a tool. The regulators can use to certify a pharmaceutical despite lacking clinical data usually needed for blanket approval. The next step is to begin. Inoculating people the trump administration's operation warp speed had already arranged for mass production of the vaccine and supply of it is already being staged around the nation. Each state is getting a pro rated number of doses along with certain cities and federal healthcare systems identified patient. Groups could start being inoculated within dave fox. Seven

Pfizer FDA EU Dave Fox
"biontech" Discussed on WSJ Minute Briefing

WSJ Minute Briefing

01:31 min | 4 months ago

"biontech" Discussed on WSJ Minute Briefing

"I asked what kind of family <Speech_Female> <Advertisement> she wanted. <Speech_Female> <Advertisement> She said <Speech_Music_Female> <Advertisement> a family <SpeakerChange> like yours. <Speech_Music_Male> <Advertisement> <Speech_Music_Male> <Advertisement> Learn more about adopting <Speech_Music_Male> <Advertisement> a teen at adopt. <Speech_Music_Male> <Advertisement> Us kids dot <Speech_Music_Male> <Advertisement> org. You can't <Speech_Male> <Advertisement> imagine the reward <Speech_Music_Male> <Advertisement> brought to <Speech_Music_Male> <Advertisement> you by the us department of <Speech_Male> <Advertisement> health and human services <Speech_Male> <Advertisement> adoptuskids and <Silence> the here's your mid daybreak <Speech_Male> for tuesday december. <Speech_Male> Eighth i'm <Speech_Male> charlie whelan for <Speech_Male> the wall street journal. <Speech_Male> The food and drug <Speech_Male> administration says <Speech_Male> a covid nineteen vaccine <Speech_Male> developed by <Speech_Male> pfizer in biontech <Speech_Male> met the <Speech_Male> agency's criteria <Speech_Male> for success <Speech_Male> the fda noted <Speech_Male> the vaccine prevented <Speech_Male> severe occurrences <Speech_Male> of the disease <Speech_Male> in addition to more <Speech_Male> moderate cases. <Speech_Male> The conclusions <Speech_Male> could pave the way for <Speech_Male> the agency to green <Speech_Male> light distribution in <Speech_Male> the us as early as <Speech_Male> this weekend. The <Speech_Male> uk began distributing <Speech_Male> vaccine today. <Speech_Male> Meanwhile <Speech_Male> astrazeneca says <Speech_Male> it'll request emergency <Speech_Male> use authorization <Speech_Music_Male> for its covid. <Speech_Music_Male> Nineteen vaccine <Speech_Male> developed with the university <Speech_Male> of oxford <Speech_Male> data from late stage. <Speech_Male> Trials provided <Speech_Male> further evidence. That cutting <Speech_Male> the first of two <Speech_Male> doses and half <Speech_Male> boosted its <Speech_Male> effectiveness. <Speech_Male> After zeneca <Speech_Male> says it will let regulators <Speech_Male> decide on how strong <Speech_Male> doses should be <Speech_Male> and the trump <Speech_Music_Male> administration's attempt <Speech_Male> to ban download <Speech_Male> the video sharing <Speech_Male> app tiktok in <Speech_Male> the. Us have <Speech_Male> been blocked by a second <Speech_Male> federal judge <Speech_Male> in august. President <Speech_Male> trump signed an <Speech_Male> order calling for tiktok <Speech_Male> to be shut down <Speech_Male> or sold. <Speech_Male> Us company fearing <Speech_Male> tiktok chinese <Speech_Male> parent could share <Speech_Male> information about us <Speech_Male> users with <Speech_Male> the chinese government. <Speech_Male> Something the company <Speech_Male> has said. It wouldn't do. <Speech_Male> We'll have a <Speech_Male> lot more coverage of the day's <Speech_Male> news on the wsj's <Speech_Male> what's news. Podcast <Speech_Male> you can add <Speech_Male> to your playlist in your <Speech_Male> smart speaker or listen and subscribe wherever you get your podcasts.

"biontech" Discussed on Marketplace Morning Report with David Brancaccio

Marketplace Morning Report with David Brancaccio

03:29 min | 4 months ago

"biontech" Discussed on Marketplace Morning Report with David Brancaccio

"Britain has secured eight hundred thousand of them safe are and have ordered a further foresee million the brits and managed to speed ahead partly because it was the first western country to give the vaccine relive tree approval forging part of the us and the rest of europe are likely to follow. She'll merit is chief commercial officer at biontech. The introduction schedule is dependent upon approval and we had originally assumed approvals earlier in the year in october in are planning. now they're coming in december. Of course there is less production but we plan to put up to one point. Three billion doses. I've the next twelve months of so. We have factories in several countries. Not just the united states and together working with countries like the united states we will continue to supply the vaccine worldwide. Faces must be trump spotted at south pole. Like temperatures though. Fight us at that. It can be stored for five days in a normal refrigerator before being used however logistical challenges. Still lie ahead to deal with delays. Uk like other countries as orders with other pharmaceutical companies. Cape ingham who is tasked with the job of securing access says that lessons learned will written face future pandemics renou have three separate flexible manufacturing sites which allows us to make different vaccines quickly and those could be marin vaccines like the fis of on tech. They can be viral vaccine oxford protein-based vaccines or whole virus vaccines and so having that flexible manufacturing capacity puts us in a very strong position and on top we now have an hsa citizen registry whereas over three hundred and sixty thousand volunteers have signed up willing to learn more about can trials potentially enrolled. We have a human challenge program that enables rapid clinical development so the uk we really are punching above our way on a global stage. Cates bingham head of the uk vaccine task force. Their cost of the program is expected to run into the billions of dollars. The mark sport is a sea of red this morning with major asian indices closing lower in europe markets is still cheering over the prospect of a post brexit trade deal between the uk and the new a bright spot for investors. Today there was hong kong's biggest initial public offering of the year shares and jd health surge..

biontech Cape ingham united states renou Britain south pole europe marin Cates bingham vaccine task force Uk oxford uk hong kong jd health
"biontech" Discussed on What A Day

What A Day

07:07 min | 4 months ago

"biontech" Discussed on What A Day

"On today's show stark warnings about the holidays from the cdc and new quarantine guidelines then some headlines. But first the latest today we can announce that the government has accepted the recommendation from the independent amid signs and healthcare products regulatory agency to approve pfizer biontech vaccine for distribution across the united kingdom after months of clinical trials involving thousands of people to ensure that the vaccine meets the strictest internationally recognized down to safety quality and effectiveness. All right that was british. Prime minister boris johnson announcing the country's emergency authorization of pfizer's corona virus vaccine. This makes the uk the first western country to authorize a vaccine. A major step in starting to bring into this pandemic russia and china have approved vaccines but without waiting for the results from large-scale trial. So how did this happen in the uk before the us. Great question and it seems to be something that was also on the mind of trump's chief of staff mark meadows who has been putting some pressure on american regulators of late to get moving a familiar thing from the white house but the basic gist of it based on reporting of the times and elsewhere is that the fda looks over raw data from the vaccine trials which is estimated to be thousands of documents that takes time whereas in the uk and across europe their regulatory agencies have tended to look at the analysis that are coming from the companies themselves in this case pfizer and biontech but in this particular case regulators in the uk said they did actually overall data and analyze tons of documentation. The times also reported that the uk has a slightly different way of getting outside opinions experts on approval where they kind of work in as needed and they deviated from the process that the rest of the european union is following which the uk is formerly brexit by the end of the year. So a bit of politics involved here as well. Though this others beat the us we know that the independent panel the fda's working with is going to meet a december tenth so it is moving right along here as well and should it be approved for authorization. The first doses are reportedly set to be delivered on december fifteenth awesome. And so how soon is all this going to be rolled out in the uk. Okay so apparently. It's actually in the next few days. Visor is going to send the initial eight hundred thousand or so doses from belgium. They packed up and dry. Ice these insanely cold temperatures and they have to be driven and delivered. It appears that the plan is to start actual vaccinations next week and the uk has reportedly enough doses for twenty million people in total plan. Thus far most of that's going to be next year and they like us have a system they put together to determine. Who is going to be getting these. I in the uk it's people who live and work in nursing homes and citizens who are older than eighty and healthcare workers. After that we'll get into more on what the us plan is a second so that's visor than the other vaccine company has submitted for use in the us is moderna and they announced yesterday that they're gonna start testing they're vaccine in children between the ages of twelve and seventeen doesn't seem like they're actually going to start just yet but they're looking to recruit about three thousand people for that trial when they end up doing it and so some experts have said that one of the main things to be on the lookout for in and try like this is kids possibly having stronger reactions due to more active immune systems and visor reportedly already started testing in children as young as twelve in october. So that is all on the horizon with approvals and trials in the fda exciting and fun stuff. But let's talk about the other big piece of this as we mentioned who will get these vaccines in the us. I and how so akilah take us through that part. Okay so obviously. This brings us to the cdc earlier this week. We talked about a meeting to give advice to states. On vaccine distribution remember states not the federal government are the ones that will be in charge of the rollout. But this advice will likely become the official. Cdc recommendation that most states are expected to rely on. the advisory committee. Said what we expected. They voted thirteen to one to prioritize. Healthcare workers and people in long term care facilities to get the vaccine. I state have until tomorrow to tell the federal government where they want their initial doses sent. So this is all happening. Incredibly quickly and in terms of how the doses will get delivered hospitals and other health clinics will give scenes to healthcare workers and according to reporting companies like cvs and walgreens will administer vaccine's too long term care facilities. These companies already have programs to do this for the flu vaccine each year though the logistics are obviously different for that. You know these new covid vaccine which requires subzero. Storage and two doses. A month apart each state is going to have its own logistics. So exactly how. This goes could vary around the country. And it'll be an early test of how this whole vaccination process is gonna work also in cdc news. Yesterday they had some pretty intense warnings about the holidays and what americans should do so what always said their intense is right. Yeah i mean they started off by recommending against travel pretty point blank but i think they and we and everyone with a pulse knows that this is not going to happen for everyone for various reasons. In fact we saw quite a bit of travel over thanksgiving. Despite similar warnings this guidance though was accompanied by some extremely grim words from cdc director. Dr robert redfield and right now it is so important that we recommit ourselves to this mitigation as we now begin to turn the corner with the vaccine but the reality is december and january and february are going to be rough times. I actually believe they're going to be the most difficult. I'm in the public health history of this nation Largely because of the stress. That's gonna put on our house that is really bleak yes He also said that the country could see close to four hundred fifty thousand cumulative deaths by february but that it's in our power to mitigate that with mask wearing and all the other protocols we we're all too familiar with at this point and to underline this grim point he was making according to covid tracking project. Yesterday the us hit over a hundred thousand people in the hospital for the first time ever also yesterday over twenty seven hundred americans died which is close to the single day high. We saw in april and one other piece of guidance came out yesterday that we should go over because it will affect people who do plan to travel around this time of year. So what was this new bit on. Quarantining all right. So the cdc also put out their own recommendations for how to shorten two week quarantine that they've been pushing travelers. Here's how that would work if you have no symptoms and tested negative for the virus. The cdc is saying you can actually stop your quarantine. After seven days. You should take another cova test at the end of the short and quarantine though to be sure and they say that rapid tests are fine. A of info has come out about the reliability of rapid test. But who am i to argue with the cdc guidance like your crazy uncle on facebook. The cd's chief medical officer explained that there is going to be an increase risk. If you go this route so still best option is a stay home and try again next year but if you do plan to travel here are the best time to get tested. According to the cdc so one to three before a trip and again three to five days after five has been the observed median incubation period for the virus. And don't plan to do anything. Non essential for a week after return right. The vacation is whenever and you come back. You gotta sit at home for a week. So it's a lot to consider re travel but if you're gonna risk it please be smart about it and again the cd's.

uk pfizer cdc mark meadows fda biontech us boris johnson akilah federal government white house european union russia The times Dr robert redfield belgium china europe government walgreens
"biontech" Discussed on Here & Now

Here & Now

05:51 min | 4 months ago

"biontech" Discussed on Here & Now

"From npr and wbz. You are dowd. I'm robin young. It's here now and we want to get right to today's major covid nineteen development the uk's approval of a vaccine the first country to take that step clearing the way for vaccinations there soon. As in the us when a program starts here in the uk elderly residents of nursing homes and frontline healthcare workers will be the first to get the shots developed by pfizer and the german company biontech pfizer says eight hundred thousand doses are doing the uk in the coming days. The country has a population of sixty six million british prime minister boris johnson who survived his own serious case of covid. Nineteen spoke in the house of commons. Today i would like to pay tribute to thank all those who made this possible. It is the protection of vaccines that will ultimately allow us to reclaim our lives and get our economy moving again. Jason bourne is npr's global health and development correspondent so jason. You've been scanning the globe. Your thoughts on this milestone today absolutely. It's a big deal. This is the moment. We've all been waiting for right when vaccine starts to actually be available to the general public Supplies are gonna be limited in the beginning and we need to underscore that. This is a pfizer vaccine that we're talking about it's just one of the vaccines but it really is remarkable. How quickly they've managed to get this from scratch all the way to the approval stage and it's not just visor you've got these other ones that are in the works to but normally would take fifteen to twenty years to do this a year ago. We hadn't even heard of. Sarah sylvie two and here. They've done this in a matter of months. It's really it's hard under state. How important remarkable. This is using the real scientific name for covid nineteen. But what's your biggest concern as the uk starts to raw the vaccine as other countries watch. Yeah i mean there's gonna be issues. One is just the logistics. As i mentioned. This is the pfizer vaccine. So this is the one takes incredibly low temperature for storage at it's minus seventy centigrade needs at at certain points in time when it's when it's being stored and transported so logistically this is not going to be an easy task to get the vaccine all the different places it needs to get to get people vaccinated but it's doable but there could be some logistical challenges. Second is going to be concerned. That we're going from vaccinating. Tens of thousands of people during these trials to now. You're gonna start giving it to millions of people and that after some of these people get the shots. Some of them are going to have some medical issue. Maybe they were just about to have a heart attack it. That is going to happen when you start giving this to such a large pool of people in questions are gonna come up about. Was that an adverse reaction to to this vaccine might have nothing to do with the vaccine but these are the types of issues on that could lead some resistance stumbling blocks some questions about the vaccine in the months ahead and just look globally for us for a second which countries have managed to control infection rates. Well what lessons can we learn. Some of the european countries have done quite well. You look at france and spain over the last month. They've brought their second waves down significantly. Ireland also seems to have gotten fully passed. Its second peak. The numbers continue to remain really quite low in africa Places like chile had a big surge in june and then they brought it down to relatively low numbers and they have managed to avoid a second wave entirely. Like we've seen in some other places so it's really different in different parts of the world but there are definitely examples out there of places that have managed to do it successfully and keep their numbers either. Bring them down after a second peak or keep them low right and what about the people who have been to be kind stuttering Here in the us. We're seeing huge numbers of cases. Every day where are the other troublespots yet the us still continues to dominate this pandemic globally with one out of every four cases being in the us but after the us then at the moment it's india brazil. Italy and russia in that order in eight is interesting to sort of look at this You know eighty percent of both the cases and the deaths are in either the americas or in europe. It's really been these two regions that have borne the brunt of this. I'm an even this week. documents from the world health organization. Said he's very concerned about mexico and brazil and the rising numbers there so there are definitely places that are that are not doing so well we just have a few seconds here but i think i know the answer this question. Yes the vaccine is coming. It's coming faster to the uk but the virus still winning at this point isn't it unfortunately. Is this pandemic continues to grow. Even as we see it ebb and flow and certain places. The numbers continue to to come more and more each week and they come faster and faster so yes. The news about the vaccine is very important to actually slow the of the virus that we're seeing globally but the virus is still there jason bobi. Npr's global health and development correspondent. Thank you. you're welcome well here in the us classes in baltimore county's public schools resumed today a week after a cyber attack. Force them to shut down and hackers held the systems data hostage. This is happening at schools around the country. The attacker's identity is usually known. They often demand. Hefty ransoms to unlock the computers in the fbi. Says we should expect more to come joining us now. Tunnel hobbs education reporter for the wall street journal. Thanks for taking the time brown..

pfizer uk robin young biontech pfizer npr Sarah sylvie dowd Jason bourne boris johnson house of commons us jason heart attack brazil chile spain Ireland france
"biontech" Discussed on TIME's Top Stories

TIME's Top Stories

03:53 min | 4 months ago

"biontech" Discussed on TIME's Top Stories

"Pfizer and bio. Intech say. They've won permission wednesday for emergency use of their covid nineteen vaccine in britain. The world's first corona virus shot that's backed by rigorous science and a major step toward eventually ending the pandemic. the move makes britain one of the first countries to begin vaccinating. Its population as it tries to curb. Europe's deadliest covid nineteen outbreak. Other countries aren't far behind the us. And the european union also are vetting. The pfizer shot along with a similar vaccine made by competitor. Moderna inc pfizer said it would immediately begin shipping limited supplies to the uk and has been gearing up for even wider distribution if given a similar nod by the us food and drug administration. A decision expected as early as next week but doses everywhere are scarce and initial. Supplies will be rationed until more is manufactured in the first several months of next year visor. Co albert birla called the uk decision. A moment we are focusing on moving with the same level of urgency to safely supply. A high quality vaccine around the world bore said in a statement while the uk has altered enough pfizer vaccine for twenty million people. It's not clear. How many will arrive. By year's end. And adding to the distribution challenges is that it must be stored at ultra cold temperatures two doses. Three weeks apart are required for protection first in line. The uk government says our frontline healthcare workers and nursing home residents followed by older adults british regulators. Also were considering. Another shot made by astrazeneca and oxford university but prime minister. Boris johnson has warned. We must i navigate a hard winter of restrictions to try to curb the virus until there's enough vaccine to go around. Every country has different rules determining when an experimental vaccine is safe and effective enough to use intense political pressure to be the first to roll out a rigorously. Scientifically tested shot colored the race in the us and britain even as researchers pledged to cut no corners and contrast china and russia have offered different vaccinations to their citizens ahead of late. Stage testing the shots made by us based pfizer and its german partner bio intech were tested in tens of thousands of people and while that study isn't complete early results suggest. The vaccine is ninety five percent effective at preventing mild to severe covid nineteen disease the company's told regulators that of the first one hundred seventy infections detected in study volunteers. Only eight were among people who'd received the actual vaccine and the rest had gotten a dummy shot. This is an extraordinarily strong protection. Dr uber sahin. A bio intex. Ceo recently told the associated press. The companies are reported. No serious side effects. Although vaccine recipients may experience temporary pain and flu-like reactions immediately after injections but experts caution that a vaccine cleared for emergency use is still experimental and the final testing must be completed still to be determined is whether the pfizer bio tech shots protect against people spreading the coronavirus without showing symptoms. Another question is how long protection lasts. The vaccine also has been tested in only a small number of children none younger than twelve. And there's no information on its effects in pregnant women.

pfizer Moderna inc britain us food and drug administratio uk albert birla lauren european union bio intech Boris johnson astrazeneca us Europe oxford university Dr uber sahin russia china the associated press
"biontech" Discussed on WSJ Minute Briefing

WSJ Minute Briefing

01:45 min | 4 months ago

"biontech" Discussed on WSJ Minute Briefing

"This episode is sponsored by. Sap your business and sap solutions together. We got this. Here's your morning brief for wednesday december. Second i'm keith collins. For the wall street journal the uk is become the first western nation to authorize the emergency use of covid nineteen vaccine developed by pfizer and partner biontech. The uk health secretary said an initial eight hundred thousand doses are expected to arrive next week and the government is expecting many millions of doses by year's end. Us health regulators are currently reviewing the vaccine and could authorize. Its emergency use later this month. Cdc advisory panel yesterday recommended that the first vaccines in the us be given to about twenty one million healthcare workers and around three million residents of long term care facilities. The cdc is likely to make a decision on the matter today. Marks asia ended mixed and european stocks fell in early trading. This after wall street kicked off the month with a rally on the heels of a strong november amazon city group and ford among more than forty big. Us companies calling on congress in the incoming biden administration to address the threat of climate change in a letter to be sent today to lawmakers and the biden transition team the companies also said they support the us reversing the trump administration's withdrawal from the paris climate accord. We have a lot more coverage of the day's news and the wsj's what's news podcast. You can add it to your playlists on your smart speaker or listening. Subscribe where you get your podcasts. Twenty twenty didn't see. That one coming disrupted supply. Chains employs working from home customers changing their minds at sap. We've helped hundreds of thousands of companies face their business challenges together. We got this. Learn more at sap dot com slash together..

"biontech" Discussed on Here & Now

Here & Now

01:54 min | 4 months ago

"biontech" Discussed on Here & Now

"Social toll has been on all of us. We have the tools we have the innovation and the companies to do all of this in a coordinated fashion and frankly in a way that is really not that difficult harvard epidemiologist michael meal maliki to his writing and here. Now dr meet up doesn't mean a thank you thank you very much. The drugmaker maduna said today that it will ask. Us in european regulators to authorize emergency use of its corona virus vaccine after trial results. Showed it to be ninety. Four percent effective pfizer is also trying to get government approval for its vaccine and so is the british drugmaker astrazeneca but even when a vaccine is ready. There's still the question of how to get it to billions of people around the world allen you from. Whyy the pulse. Talk to some people working on that. Logistical challenge to deliver billions of doses of vaccine. You have to think about a lot of small details. David monster calvo is handling one of them. He's the chief operations and supply chain officer of west pharmaceutical services a global company with headquarters in pennsylvania. Each year we makeup billions of stoppers plungers seals. That are used with vials syringes in partridges. His company has hired an extra five hundred people to their team of eight thousand to make sure they are enough of those stoppers for a covert nineteen vaccine as we like to see. Every component has a patient's name on it once you can hold the vaccines you need to get them to people a lot of vaccines need to stay cold. Vaccines are sensitive biological products. Some of them are living so you need to keep those at the right temperatures.

michael meal maliki maduna David monster calvo west pharmaceutical services harvard astrazeneca pfizer allen Us pennsylvania
"biontech" Discussed on The Journal.

The Journal.

03:29 min | 5 months ago

"biontech" Discussed on The Journal.

"Dot com slash journal doctors. He believed he had the technology to make an effective covid vaccine. But biontech as a company didn't have the size to get that vaccine tested and manufactured at the scale and speed it needed to and that's what led doctors to link up with a company that he'd worked with before the giant us-based drug company pfizer so the first of march i think he called catcher in johnson who is in charge of vaccine program with with pfizer. And he said kiosks her. Would you like to work with me on my new project. Which is basically i making a vaccine for coronavirus and interestingly dr johnson didn't really ask any questions you just said yes absolutely. This is the most important thing that will ever do. Probably and in record time they managed to forge this contract. They have and essentially deal is to split costs and revenues down the middle. So it's fifty fifty for both companies. Pfizer is a major pharmaceutical company. Why do they need to team. Up with dr zion and biontech to make this vaccine is kind of brain and muscle. Pfizer is a giant but it doesn't have for example this type of innovation innovation happens typically in small companies essentially pfizer needed by tag because they had the vaccine and bond techniques because visor had the global network to make it happen pfizer undertook to organize the so-called face three trials which are the most important trials they involve in this case around forty four thousand people around the world who were injected with the vaccine and they had to be monitored and the data had to be collected and analyzed and i think pfizer had the capacity to do that really well. What biontech is doing is truly innovative. They're using technology called messenger. Aren a or m are in a so. Any vaccine will try and create immunity in the body to particular pathogens is targeting. Let's say you take bach standard influenza vaccine of flu influence. A vaccine will just trick your body into believing that it has been infected influence. Traditionally vaccines teach the body. How to fend off. Virus by using a neutralized version of that virus. The party will create the immune response. Antibodies and then the next time you voted gets infected with the virus it will be able to fend it off but the biontech vaccine does something different. Instead of using neutralize version of the virus it sends messengers the m in the mariana and those messengers. Tell your body how to.

pfizer dr johnson biontech flu dr zion
"biontech" Discussed on Democracy Now! Audio

Democracy Now! Audio

03:30 min | 5 months ago

"biontech" Discussed on Democracy Now! Audio

"That's reassuring that vaccines targeting. That seemed to be working. The third thing is that the technology both of them seem to be working so these are good new. This is part of good news. There's lots to be known for example. We need to know how long it's going to work. We need a little bit more detail safety data and the way it is likely to be approved is likely to be or authorized. It's likely to go to the fda now about the companies have indicated. They're going to go to the fifty and within the next few weeks and fda has had a little bit of course correction in the past four or five weeks where they have been more open about following the mainstream process and frankly due to the pushback from the career folks there but but that is reassuring and the. It's likely that these vaccines will be the data from these vaccines. Even more detail. Data will be presented to the advisory committee independent advisory committee of the fda and fda itself and then a decision will be made so talk about what's needed for distribution. We understand that the pfizer biontech double vaccine you. Need two of them has to be kept at sub zero temperatures. Many states are deeply concerned in the united states not to mention countries around the world. And you're deeply involved with both as you're involved with the world health organization. Do not have the special freezers. That are needed. Madera is different though. It still needs freezers. Yes so we call that. Ultra cool chain requirement for something like what would be required for the pfizer biontech and that is a problem That is actually. I would say it's a challenge. It's not unsurmountable because the vaccine was distributed in a lower income countries situation using culture call gene. So it's not impossible but it's a pretty substantial challenge and who has been focusing on this in anticipation in terms of country preparedness. Look preparing the kind of you know. The world is not easy similarly in the us. I wish we had been planning a little bit. We had started planning a little bit earlier. But the cdc has released a few documents has been working with several states to get us online as a country to prepare for vaccines that require ultra chain. But that doesn't mean that it's not gonna pose challenges it's going to pose substantial challenges especially my concern is in terms of equity so people who have access to facilities Both physical and otherwise that have these kinds of requirements have are different from people who don't have access to these facilities and so and so forth so it is not unsurmountable but we need to work hard towards it and talk about what this means for who has access and who doesn't both in the united states but also around the world you're involved with the world health organization Can you talk about how these vaccines will be distributed already..

fda united states pfizer biontech cdc Madera
"biontech" Discussed on This Week with George Stephanopoulos

This Week with George Stephanopoulos

05:02 min | 5 months ago

"biontech" Discussed on This Week with George Stephanopoulos

"An admiral we know who is not shouting that message to the american public and that is donald trump. the washington post is reporting this morning that the president has not attended a corona virus task force meeting in at least five months. Is that accurate. That's true but the vice president Does chair the corona virus task force The vice president. We often have several cabinet members there and the vice president breeze the the president every day or nearly every day on corona virus so. I'm not concerned that the president doesn't attend the vice. President is there secretary as are the leadership. that's there the scientific community dr burks. Dr fauci myself. Dr han dr redfield. We're all working in the docks work literally every single day together. We put out over fifty million of the card based test. Another eight and a half million this week at admiral. I wanna only antibody sorry to interrupt you on that. We're just short on time. Here of operation warp speed monsef slough. Who stood by the president on friday is calling on the white house to allow his team to make contact with the biden. Cova transmission team which is being held up by the president who's not accepting the election results. Do you agree. They should be given access and talk to the biden cova team. So i'm not dr slowly i can say from from my point of view that the gsa couldn't controls the transition process My team all the docs at work for us. We want to be extremely transparent We are extremely transparent with the media with outside experts with public health experts. Some of it is important to be able to talk to the biden team at this point just to yes or no look i want to be as transparent as possible with everybody. This is not a political issue. This is an issue of public health and saving american lives. And i think there's nothing more important than that. Okay thank you very much. Admiral and we want to bring in dr toga juande dutch gandhi. Good to see you. You heard what he just said about that. How important is that transition. It's important working with the transition team they are. I'm advising them and they are. They're ready to go and and are getting all the information they can. But you're talking about the biden transition team out mostly it. It is in the nation's interests that the transition team get the threat assessments that the team knows about the Understand the vaccine distribution plans need to know where the stockpiles are. What the status is masks and gloves. There's a lot of information that needs to be transmitted a camp to the last. You can hear him. Admiral gerard voice. The doctors and scientists want to give that information it is vital. And and what do you believe needs be done to stop this surgeon you also i believe heard those voters saying look. I don't believe it what needs to be done. That has not been done in this administration. Well number one is a clear voice from the top backing a national comprehensive plan and we've lacked that it's led to disarray for the public and confusing messages. That will change. I think number two is mask wearing admiral. Drawer says this that that the evidence is overwhelming that this can stop in reverse spread what i would say. I want to say to those Those citizens is simply that When a person goes into a store and does not wear a mask when they go to public gathering and are not math. They're hurting everyone's freedom. They are Putting people in danger moreover they are turning people away from shops and stores. And that's hurting jobs. That is the critical mix of things opposing masters. Like opposing washing hands. It's not political. we can pull together. We can do this and dr gandhi just quickly. If you will want clear the substance another member of the task force suggested there could be a four six shutdown nationwide. Is there a scenario where that could happen. We are not in support of a nationwide lockdown and believe there is not a scenario unless there simply isn't a scenario because we can get this under control. The critical parts are understanding what we've learned since we did a nationwide lockdown in early april. And that is that you can have targeted measures Building on mass wearing to include widespread testing can include dialing up and down capacity restrictions. And those measures need to happen in a more localised basis. You can look at new york city for example where on zip code by zip code basis you can deploy different Different restrictions in order to get a the virus under control. And it's quite effective. We do not need to go into a nationwide shelter in place shopping. Okay thank you so much for joining us this morning. Guarini always good to see.

vice president biden cova team dr burks Dr han dr redfield biden Dr fauci Admiral gerard voice washington post dr gandhi donald trump. new york Guarini secretary Drawer
"biontech" Discussed on The Daily Dive

The Daily Dive

06:42 min | 9 months ago

"biontech" Discussed on The Daily Dive

"Twenty Third I'm Oscar Ramirez in Los Angeles, and this is the daily died. The. US has agreed to pay Pfizer and bio tech nearly two billion dollars secure one hundred million doses of experimental corona virus vaccine. It's still needs to go through face to be trials and be approved by the FDA, but the races onto spears. Many doses possible. Operation Warp, speed construct similar deals with other vaccine developers as well. Jared Hopkins Arm Reporter at The Wall Street Journal joins us for all the money. Being poured into vaccine. Next Congress continues to debate what to do about enhanced jobless benefits that are set to expire at the end of next week. Some twenty five million Americans are set to lose an X. Six hundred dollars a week that were given out to help. Keep people afloat during the pandemic shutdown. Eric Morath Labor Economics and policy reporter the Wall Street. Journal joins US for more. Finally the culture war over wearing face masks continue and California. The city of Huntington beach has become the symbol of mass resists. Spite evidence that face coverings help limit the spread of rotavirus. Some residents sneath viruses over hype. Others are just fed up with constantly changing restriction. Jake Sheridan reporter at La Times joins US for white facemasks continue to be a point of contention. At the North that stuyvesant. Administration reached a historic agreement with Pfizer. To Produce and deliver one hundred million doses of vaccine, immediately following its approval. Jared Hopkins Armagh reporter for the wall. Street Journal thanks for joining US Jerry. Driving me. We're getting a lot of news actually about vaccines this past week and steadily over the past few weeks. We're getting into phase three trials. In many cases, a lot of good news is coming out, but I wanted to talk about the money associated with these vaccines be us. Government is pouring billions of dollars into various companies and vaccine candidates to secure A. A bunch of doses. This is obviously pending them completing their three channels and actually getting approved, they just want to have the doses ready to supply to Americans and in the latest news. We have a nearly two billion dollar agreement between Pfizer and bio N Tek who has their vaccine candidate going into phase three trials going pretty soon. Jer Tell us about this deal. announced this morning that the US government has a read to pay visor and biotech, almost two billion dollars for one hundred million doses. Should their vaccines for Kobe nineteen proved to work safely which could happen later this year? That's the essence of it and at the US. Government has the option to hire an additional five hundred million doses in the future. Remains to be seen if they want to do that so far, but this is also the largest US government funding mechanism so far because they've invested in a number of efforts so far for. Working on Kovic Treatments and Cova Da Vaccines. Some of the latest news that we've heard out of the vaccine candidate from Astra Zeneca in Oxford University. We also heard it about Madonna that they're generally safe and they are producing an immune response. I'm assuming that's the same for this. Pfizer, bio and tech vaccine candidate. Joe All three vaccine candidates from these companies and researchers have. Shown so far enough in small studies to be safe and to generate and immune response, the studies are small or smaller, and what happens is that they then move onto a larger face study where they're tested in thousands of patients, all three of these candidates are slated to be tested in thirty thousand people in the US with Pfizer and Maderna's scheduled start this month at some point before the end of the month, and then the Oxford slash. Ask Antica. One is supposed to start its large scale study next month. Minor standing is already starting to manufacture a lot of the vaccine so that once it's proven effective, and they get approval can start shipping it out to various countries and everything. There's a big push right now or jockeying I guess among nations in the US in terms of securing supplies and securing vaccine supplies such as vials, and so we're seeing a lot of countries try to sort of get ahead of this in terms of when they might be approved or authorized to be used by the public in the US they have something called the emergency use authorization, which the government can authorize a vaccine or drug approval on a on a limited basis and that could come as early as this. This year at some point for Pfizer bioinformatic their vaccines, they plan to file for such an emergency relation in October. That's their current plan. If if they're trial goes as well and and the vaccine is proven to work and safely as to win, the government will then grant that authorization. You know it could come in days or weeks after it's filed, we saw earlier this year that the antiviral rim desert veer from Gilead after it show positive results in a study, the US government granted. It's emergency authorization within several days. And, how does this Pfizer? Vaccine work, it's using a gene based technology known as Messenger, aren A, and there's no vaccine that has actually been approved uses this Mri a technique. So it's an unproven technology that Madeira and Biotech vaccines or are on, but essentially a messenger aren a carries instructions from DNA to the body cells to make certain protein you know, and then that process goes towards. Creating protection potentially against the virus, but to your point and Vaccine has never been approved to prevent any infectious disease. Jared, Hopkins Armagh Reporter at the Wall Street Journal. Thank you very much for joining us. Thank you. It's a great time to get a great deal on a new car. When you get approved for an auto loan from Pinhead, our powered by truecar rates are as low as one point three nine percent APR on New Vehicles Finance for a longer term to lower your monthly bill plus take up to sixty days to schedule your first payments. Join Fed and together. We'll keep you.

Pfizer US Jared Hopkins US government reporter The Wall Street Journal Oscar Ramirez Reporter Los Angeles Hopkins Armagh Reporter FDA California Jake Sheridan Huntington beach Fed Street Journal Astra Zeneca Cova Da Vaccines Eric Morath stuyvesant